READING, MA--(Marketwire - January 29, 2009) -
InfoMedics, Inc., the leader in patient
feedback solutions, today reported a strong growth in business in 2008 and
a positive start to 2009. The company credits its success to a continued
increase in the scope of solutions offered by InfoMedics, coupled with
innovative new products designed to differentiate clients' brands in a
crowded and challenged industry.
The company has increased its average program size by 30 percent since
2006. At just one month into the year, InfoMedics has scheduled development
of more than half the total number of programs which the company launched
in all of 2008. InfoMedics continues to expand its reach into a wide range
of therapeutic categories, including oncology, neurology and pulmonology.
"2008 was a challenging year for the pharmaceutical industry, as we saw the
decline of the blockbuster drug and increased scrutiny of traditional
marketing practices," said Gene Guselli, CEO, InfoMedics. "Budgets were
tight, marketing programs were held to a higher standard, and we are proud
to say we met those challenges head on. Our launch phase programs delivered
an average overall NRx lift of 173% among physicians last year, and our
programs continued to deliver an average ROI of 4:1 for our clients."
InfoMedics' communications platform also forms the base for the new
Adherence Driver™ product which was introduced in October 2008.
Adherence DriverTM, is the first adherence solution to analyze and address
each patient's unique treatment challenges, and open critical lines of
communication to their prescribing physician.
"Adherence Driver is a program for the time," said Stanley Wulf, MD, vice
president and chief medical officer, InfoMedics. "With an average of 36%
of pharma sales lost due to non-adherence, it's no surprise that pharma
companies are seeking a configurable and scalable solution that will
generate predictable results."
InfoMedics is also experiencing a broader demand for its communications
platform throughout the product lifecycle, including pre-launch.
Guselli added, "There is no question that clients see huge value in
utilizing the patient feedback platform as a core solution for increasing
physicians' awareness of their patient's challenges and unmet needs in
certain medical conditions. We anticipate continued increase in demand and
scope for these services especially in the current pharmaceutical marketing
environment."
About InfoMedics, Inc.
InfoMedics, Inc. is the only pharmaceutical services provider that delivers
clear, actionable patient feedback to physicians; this feedback is designed
to improve patient-physician communications while providing brand insight
to pharmaceutical manufacturers. Patient feedback assists physicians at the
point-of-care to optimize treatment outcomes and improve medication
compliance. InfoMedics' programs facilitate the communication channel
between physicians and patients around the prescribed pharmaceutical
treatment, enhancing awareness and accelerating market share growth.
InfoMedics works with the world's top 15 pharmaceutical companies. The
company's programs increase average brand prescribing by 40% and deliver an
average ROI of 4:1. For more information about InfoMedics, visit
www.infomedics.com.
